Nonrandom Chromosome Abnormalities in Cancer-An Overview

Cancer Cytogenetics

Volumn , Issue , 2010, Pages 25-43

  Helm, Sverre ^a   Mitelman, Felix ^b  

^a OSLO UNIVERSITY HOSPITAL   (Norway)

^b LUND UNIVERSITY   (Sweden)

Author keywords

Comparative genomic hybridization; Cytogenetic techniques; Karyotypic abnormalities; Nonrandom chromosome abnormalities; Philadelphia chromosome

Indexed keywords

EID: 84886317104     PISSN: None     EISSN: None     Source Type: Book    
DOI: 10.1002/9781118010136.ch4     Document Type: Chapter

References (89)

1. Allies LE, Weissman IL (2007): Cancer stem cells in solid tumors. Curr Opin Biotechnol 18:460-466.
2. Apian PD (2006): Causes of oncogenic chromosomal translocation. Trends Genet 22:46-55.
3. Basecke J, Griesinger F, Triimper L, Brittinger G (2002): Leukemia- and lymphoma-associated genetic aberrations in healthy individuals. Ann Hematol 81:64-75.
4. Bonassi S, Ugolini D, Kirsch-Volders M, Stromberg U, Vermeulen R, Tucker JD (2005): Human population studies with cytogenetic biomarkers: review of the literature and future prospectives. Environ Mol Mutagen 45:258-270.
5. Boveri T (1914): Zur Frage der Entstehung maligner Tumoren. Jena, Germany: Gustav Fischer.
6. Broberg K, Toksvig-Larsen S, Lindstrand A, Mertens F (2001): Trisomy 7 accumulates with age in solid tumors and non-neoplastic synovia. Genes Chromosomes Cancer 30:310-315.
7. Campbell PJ, Stephens PJ, Pleasance ED, O'Meara S, Li H, Santarius T, Stebbings LA, Leroy C, Edkins S, Hardy C, Teague JW, Menzies A, Goodhead J, Turner DJ, Clee CM, Quail MA, Cox A, Brown C, Durbin R, Hurles ME, Edwards PAW, Bignell GR, Stratton MR, Futreal PA (2008): Identification of somatically acquired rearrangements in cancer using genome-wide massively parallel paired-end sequencing. Nat Genet 40:722-729.
8. Cardoso J, Boer J, Morreau H, Fodde R (2007): Expression and genomic profiling of colorectal cancer. Biochim Biophys Acta Rev Cancer 1775:103-137.
9. Castor A, Nilsson L, Astrand-Grundstrom I, Buitenhuis M, Ramirez C, Anderson K, Strombeck B, Garwicz S, Bekassy AN, Schmiegelow K, Lausen B, Hokland P, Lehmann S, Juliusson G, Johansson B, Jacobsen SE (2005): Distinct patterns of hematopoietic stem cell involvement in acute lymphoblastic leukemia. Nat Med 11:630-637.
10. Chiu BC, Dave BJ, Blair A, Gapstur SM, Zahm SH, Weisenburger DD (2006): Agricultural pesticide use and risk of t(14;18)-defined subtypes of non-Hodgkin lymphoma. Blood 108:1363-1369.
11. Clark SJ (2007): Action at a distance: epigenetic silencing of large chromosomal regions in carcinogenesis. Hum Mol Genet 16:Spec No 1 R88-R95.
12. Cowell JK, Nowak NJ (2003): High-resolution analysis of genetic events in cancer cells using bacterial artificial chromosome arrays and comparative genome hybridization. Adv Cancer Res 90:91-125.
13. Cremer T, Cremer M, Dietzel S, Miiller S, Solovei I, Fakan S (2006): Chromosome territories-a functional nuclear landscape. Curr Opin Cell Biol 18:307-316.
14. Digweed M, Sperling K (2004): Nijmegen breakage syndrome: clinical manifestation of defective response to DNA double-strand breaks. DNA Repair 3:1207-1217.
15. Druker BJ (2004): Imatinib as a paradigm of targeted therapies. Adv Cancer Res 91:1-30.
16. Ebert BL, Pretz J, Bosco J, Chang CY, Tamayo P, Galili N, Raza A, Root DE, Attar E, Ellis SR, Golub TR (2008): Identification of RPS14 as a 5q- syndrome gene by RNA interference screen. Nature 451:335-339.
17. Escobar PA, Smith MT, Vasishta A, Hubbard AE, Zhang L (2007): Leukaemia-specific chromosome damage detected by comet with fluorescence in situ hybridization (comet-FTSH). Mutagenesis 22:321-327.
18. Eyfjord JE, Bodvarsdottir SK (2005): Genomic instability and cancer: networks involved in response to DNA damage. Mutal Res 592:18-28.
19. Gauwerky CE, Hoxie J, Nowell PC, Croce CM (1988): Pre-B-cell leukemia with a t(8;14) and a t(14; 18) translocation is preceded by follicular lymphoma. Oncogene 2:431^435.
20. Gisselsson D (2005): Mitotic instability in cancer: is there method in the madness? Cell Cycle 4:1007-1010
21. Greaves MF, Wiemels J (2003): Origins of chromosome translocations in childhood leukaemia. Nat Rev Cancer 3:639-649.
22. Greenman C, Stephens P, Smith R, Dalgliesh GL, Hunter C, Bignell G, Davies H, Teague J, Butler A, Stevens C, Edkins S, O'Meara S, Vastrik I, Schmidt EE, Avis T, Barthorpe S, Bhamra G, Buck G, Choudhury B, Clements J, Cole J, Dicks E, Forbes S, Gray K, Halliday K, Harrison R, Hills K, Hinton J, Jenkinson A, Jones D, Menzies A, Mironenko T, Perry J, Raine K, Richardson D, Shepherd R, Small A, Tofts C, Varian J, Webb T, West S, Widaa S, Yates A, Cahill DP, Louis DN, Goldstraw P, Nicholson AG, Brasseur F, Looijenga L, Weber BL, Chiew YE, DeFazio A, Greaves MF, Green AR, Campbell P, Birney E, Easton DF, Chenevix-Trench G, Tan MH, Khoo SK, Teh BT, Yuen ST, Leung SY, Wooster R, Futreal PA, Stratton MR (2007): Patterns of somatic mutations in human cancer genomes. Nature 446:153-158.
23. Gronbaek K, Hother C, Jones PA (2007): Epigenetic changes in cancer. APMIS 115:1039-1059.
24. Heim S (1992): Is cytogenetics reducible to the molecular genetics of cancer cells? Genes Chromosomes Cancer 5:188-196
25. Heim S (1993): Tumor progression-karyotypic keys to multistage pathogenesis. In: Iversen OH, editor. New Frontiers in Cancer Causation: Exploring New Frontiers. Washington, DC: Hemisphere Publishing Corporation, pp 247-259.
26. Heim S, Mitelman F (1989): Primary chromosome abnormalities in human neoplasia. Adv Cancer Res 52:1-44.
27. Heim S, Mandahl N, Mitelman F (1988): Genetic convergence and divergence in tumor progression. Cancer Res 48:5911-5916.
28. Heim S, Christensen BE, Fioretos T, Sorensen AG, Pedersen NT (1992): Acute myelomonocytic leukemia with inv(16)(p 13q22) complicating Philadelphia chromosome positive chronic myeloid leukemia. Cancer Genet Cytogenet 59:35-38.
29. Hong D, Gupta R, Anclif TP, Atzberger A, Brown J, Soneji S, Green J, Colman S, Piacibello W, Buckle V, Tsuzuki S, Greaves M, Enver T (2008): Initiating and cancer-propagating cells in TEL-AML1 - associated childhood leukemia. Science 319:336-339.
30. Hotfilder M, Rottgers S, Rosemann A, Schrauder A, Schrappe M, Pieters R, Jurgens H, Harbott J, Vormoor J (2005): Leukemic stem cells in childhood high-risk ALL/t(9;22) and t(4; 11) are present in primitive lymphoid-restricted CD34+CD19~ cells. Cancer Res 65:1442-1449.
31. Huntly BJP, Gilliland DG (2005): Leukaemia stem cells and the evolution of cancer-stem-cell research. Nat Rev Cancer 5:311-321.
32. Janz S, Potter M, Rabkin CS (2003): Lymphoma- and leukemia-associated chromosomal translocations in healthy individuals. Genes Chromosomes Cancer 36:211-223.
33. Jin Y, Mertens F, Mandahl N, Heim S, Olegard C, Wennerberg J, Biorklund A, Mitelman F (1993): Chromosome abnormalities in eighty-three head and neck squamous cell carcinomas: influence of culture conditions on karyotypic pattern. Cancer Res 53:2140-2146.
34. Jin Y, Martins C, Salemark L, Persson B, Jin C, Miranda J, Fonseca I, Jonsson N (2001): Nonrandom karyotypic features in basal cell carcinomas of the skin. Cancer Genet Cytogenet 131:109-119.
35. Johansson B, Mertens F, Mitelman F (1991): Geographic heterogeneity of neoplasia-associated chromosome aberrations. Genes Chromosomes Cancer 3:1-7.
36. Johansson B, Heim S, Mandahl N, Mertens F, Mitelman F (1993): Trisomy 7 in nonneoplastic cells. Genes Chromosomes Cancer 6:199-205.
37. Johansson B, Mertens F, Mitelman F (1996): Primary vs. secondary neoplasia-associated chromosomal abnormalities-balanced rearrangements vs. genomic imbalances? Genes Chromosomes Cancer 16:155-163.
38. Johansson B, Fioretos T, Mitelman F (2002): Cytogenetic and molecular genetic evolution of chronic myeloid leukemia. Acta Haematol 107:76-94.
39. Joslin JM, Fernald AA, Tennant TR, Davis EM, Kogan SC, Anastasi J, Crispino JD, Le Beau MM (2007): Haploinsufficiency of EGR1, a candidate gene in the del(5q), leads to the development of myeloid disorders. Blood 110:719-726.
40. Jurlander J, Caligiuri MA, Ruutu T, Baer MR, Strout MP, Oberkircher AR, Hoffmann L, Ball ED, Frei-Lahr DA, Christiansen NP, Block AM, Knuutila S, Herzig GP, Bloomfield CD (1996): Persistence of the AML1/ETO fusion transcript in patients treated with allogeneic bone marrow transplantation for t(8;21) leukemia. Blood 88:2183-2191.
41. Kelly LM, Gilliland DG (2002): Genetics of myeloid leukemias. Annu Rev Genomics Hum Genet 3:179-198.
42. Knudson AG (1971): Mutation and cancer: statistical study of retinoblastoma. Proc Natl Acad Sci USA 68:820-823.
43. Knutsen T, Gobu V, Knaus R, Padilla-Nash H, Augustus M, Strausberg RL, Kirsch IR, Sirotkin K, Ried T (2005): The interactive online SKY/M-FISH & CGH database and the Entrez cancer chromosomes search database: linkage of chromosomal aberrations with the genome sequence. Genes Chromosomes Cancer 44:52-64.
44. Kolomietz E, Al-Maghrabi J, Brennan S, Karaskova J, Minkin S, Lipton J, Squire JA (2001): Primary chromosomal rearrangements of leukemia are frequently accompanied by extensive submicro-scopic deletions and may lead to altered prognosis. Blood 97:3581-3588.
45. Korbel JO, Urban AE, Affourtit JP, Godwin B, Grubert F, Simons JF, Kim PM, Palejev D, Carriero NJ, Du L, Taillon BE, Chen Z, Tanzer A, Saunders AC, Chi J, Yang F, Carter NP, Hurles ME, Weissman SM, Harkins TT, Gerstein MB, Egholm M, Snyder M (2007): Paired-end mapping reveals extensive structural variation in the human genome. Science 318:420-426.
46. Kumar-Sinha C, Tomlins SA, Chinnaiyan AM (2006): Evidence of recurrent gene fusions in common epithelial tumors. Trends Mol Med 12:529-536.
47. Lannon CL, Sorensen PHB (2005): ETV6-NTRK3: a chimeric protein tyrosine kinase with transformation activity in multiple cell lineages. Semin Cancer Biol 15:215-223.
48. Lee DS, Kim SH, Seo EJ, ParkCJ, Chi HS, Ko EK, Yoon BH, Kim WH, Cho HI (2002): Predominance of trisomy 1 q in myelody splastic syndromes in Korea: is there an ethnic difference ? A 3-year multi-center study. Cancer Genet Cytogenet 132:97-101.
49. Mauritzson N, Albin M, Rylander L, Billstrom R, Ahlgren T, Mikoczy Z, Bjork J, Stromberg U, Nilsson PG, Mitelman F, Hagmar L, Johansson B (2002): Pooled analysis of clinical and cytogenetic features in treatment-related and de novo adult acute myeloid leukemia and myelody splastic syndromes based on a consecutive series of 761 patients analyzed 1976-1993 and on 5098 unselected cases reported in the literature 1974-2001. Leukemia 16:2366-2378.
50. Miremadi A, Oestergaard MZ, Pharoah PD, Caldas C (2007): Cancer genetics of epigenetic genes. Hum Mol Genet 16: Spec No 1. R28-R49.
51. Misteli T (2005): Concepts in nuclear architecture. Bio Essays 27:477-487.
52. Mitelman F (1981): Tumor etiology and chromosome pattern-evidence from human and experimental neoplasms. In: Arrighi FE, Rao PN, Stubblefield E, editors. Genes, Chromosomes, and Neoplasia. New York: Raven Press, pp 335-350.
53. Mitelman F, Mark J, Levan G, Levan A (1972): Tumor etiology and chromosome pattern. Science 176:1340-1341.
54. Mitelman F, Brandt L, Nilsson PG (1978): Relation among occupational exposure to potential mutagenic/carcinogenic agents, clinical findings, and bone marrow chromosomes in acute nonlymphocytic leukemia. Blood 52:1229-1237.
55. Mitelman F, Mertens F, Johansson B (2005): Prevalence estimates of recurrent balanced cytogenetic aberrations and gene fusions in unselected patients with neoplastic disorders. Genes Chromosomes Cancer 43:350-366.
56. Mitelman F, Johansson B, Mertens F (2007): The impact of translocations and gene fusions on cancer causation. Nat Rev Cancer 7:233-245.
57. Mitelman F, Johansson B, Mertens F, editors (2008): Mitelman Database of Chromosome Aberrations in Cancer. Available at http://cgap.nci.nih.gov/Chromosomes/Mitelman.
58. Murname JP (2006): Telomeres and chromosome instability. DMA Repair 5:1082-1092.
59. Ng P, Wei CL, Sung WK, Chiu KP, Lipovich L, Ang CC, Gupta S, Shahab A, Ridwan A, Wong CH, Liu ET, Ruan Y (2005): Gene identification signature (GIS) analysis for transcriptome characterization and genome annotation. Nat Methods 2:105-111.
60. Nowell PC (1976): The clonal evolution of tumor cell populations. Acquired genetic lability permits stepwise selection of variant sublines and underlies tumor progression. Science 194:23-28.
61. Nowell PC (1986): Mechanisms of tumor progression. Cancer Res 46:2203-2207.
62. NuciforaG, Larson RA, Rowley JD (1993): Persistence of the 8;21 translocation in patients with acute myeloid leukemia type M2 in long-term remission. Blood 82:712-715.
63. Obe G, Pfeiffer P, Savage JR, Johannes C, Goedecke W, Jeppesen P, Natarajan AT, Martinez-Lopez W, Folle GA, Drets ME (2002): Chromosomal aberrations: formation, identification and distribution. Mutat Res 504:17-36.
64. Pandis N, Bardi G, Heim S (1994): Interrelationship between methodological choices and conceptual models in solid tumor cytogenetics. Cancer Genet Cytogenet 76:77-84.
65. Pedersen-Bjergaard J, Andersen MK, Christiansen DH, Nerlov C (2002): Genetic pathways in therapy-related myelodysplasia and acute myeloid leukemia. Blood 99:1909-1912.
66. Pinkel D, Albertson DG (2005): Array comparative genomic hybridization and its applications in cancer. Nat Genet 37:SI 1-S17.
67. Platzer Upender MB, Wilson K, Willis J, Lutterbaugh J, Norratti A, Willson JKV, Mack D, Ried T, Markowitz S (2002): Silence of chromosomal amplifications in colon cancer. Cancer Res 62:1134-1138.
68. Povirk LF (2006): Biochemical mechanisms of chromosomal translocations resulting from DNA double-strand breaks. DNA Repair 5:1199-1212.
69. Rabes HM, Demidchik EP, Sidorow JD, Lengfelder E, Beimfohr C, Hoelzel D, Klugbauer S (2000): Pattern of radiation-induced RET and NTRK.1 rearrangements in 191 post-Chernobyl papillary thyroid carcinomas: biological, phenotypic, and clinical implications. Clin Cancer Res 6:1093-1103.
70. Remstein ED, Dogan A, Einerson RR, Paternoster SF, Fink SR, Law M, Dewald GW, Kurtin PJ (2006): The incidence and anatomic site specificity of chromosomal translocations in primary extranodal marginal zone B-cell lymphoma of mucosa-associated lymphoid tissue (MALT lymphoma) in North America. Am J Surg Pathol 30:1546-1553.
71. Riggi N, Cironi L, Provero P, Suva ML, Kaloulis K, Garcia-Echeverria C, Hoffmann F, Trumpp A, Stamenkovic I (2005): Development of Ewing's sarcoma from primary bone marrow-derived mesenchymal progenitor cells. Cancer Res 65:11459-11468.
72. Riggi N, Cironi L, Provero P, Suva ML, Stehle JC, Baumer K, Guillou L, Stamenkovic I (2006): Expression of the FUS-CHOP fusion protein in primary mesenchymal progenitor cells gives rise to a model of myxoid liposarcoma. Cancer Res 66:7016-7023.
73. Rikova K, Guo A, Zeng Q, Possemato A, Yu J, Haack H, Nardone J, Lee K, Reeves C, Li Y, Hu Y, Tan Z, Stokes M, Sullivan L, Mitchell J, Wetzel R, Macneill J, Ren JM, Yuan J, Bakalarski CE, Villen J, Kornhauser JM, Smith B, Li D, Zhou X, Gygi SP, Gu TL, Polakiewicz RD, Rush J, Comb MJ (2007): Global survey of phosphotyrosine signaling identifies oncogenic kinases in lung cancer. Cell 131:1190-1204.
74. Rotman G, Shiloh Y (1998): ATM: from gene to function. Hum Mol Genet 7:1555-1563.
75. Ruan Y, Ooi HS, Choo SW, Chiu KP, Zhao XD, Srinivasan KG, Yao F, Choo CY, Liu J, Ariyaratne P, Bin WG, Kuznetsov VA, Shahab A, Sung WK, Bourque G, Palanisamy N, Wei CL (2007): Fusion transcripts and transcribed retrotransposed loci discovered through comprehensive transcriptome analysis using Paired-End diTags (PETs). Genome Res 17:828-838.
76. Sales KM, Winslet MC, Seifalian AM (2007): Stem cells and cancer: an overview. Stem Cell Rev 3:249-255.
77. Schoch C, Kohlmann A, Dugas M, Kern W, Schnittger S, Haferlach T (2006): Impact of trisomy 8 on expression of genes located on chromosome 8 in different AML subgroups. Genes Chromosomes Cancer 45:1164-1168.
78. Segel MJ, Paltiel O, Zimran A, Gottschalk-Sabag S, Schibi G, Krichevski S, Ludkovski O, Ben Yehuda D (1998): Geographic variance in the frequency of the t(14; 18) translocation in follicular lymphoma: an Israeli series compared to the world. Blood Cells Mol Dis 24:62-72.
79. Sinclair PB, Nacheva EP, Leversha M, Telford N, Chang J, Reid A, Bench A, Champion K, Huntly B, Green AR (2000): Large deletions at the t(9;22) breakpoint are common and may identify a poor-prognosis subgroup of patients with chronic myeloid leukemia. Blood 95:738-743.
80. Sjoblom T, Jones S, Wood LD, Parsons DW, Lin J, Barber TD, Mandelker D, Leary RJ, Ptak J, Silliman N, Szabo S, Buckhaults P, Farrell C, Meeh P, Markowitz SD, Willis J, Dawson D, Willson JK, Gazdar AF, Hartigan J, Wu L, Liu C, Parmigiani G, Park BH, Bachman KE, Papadopoulos N, Vogelstein B, Kinzler KW, Velculescu VE (2006): The consensus coding sequences of human breast and colorectal cancers. Science 314:268-274.
81. Smith MT, Zhang L, Wang Y, Hayes RB, Li G, Wiemels J, Dosemeci M, Titenko-Holland N, Xi L, Kolachana P, Yin S, Rothman N (1998): Increased translocations and aneusomy in chromosomes 8 and 21 among workers exposed to benzene. Cancer Res 10:2176-2181.
82. Soda M, Choi YL, Enomoto M, Takada S, Yamashita Y, Ishikawa S, Fujiwara S, Watanabe H, Kurashina K, Hatanaka H, Bando M, Ohno S, Ishikawa Y, Aburatani H, Niki T, Sohara Y, Sugiyama Y, Mano H (2007): Identification of the transforming EML4-ALK fusion gene in non-small-cell lung cancer. Nature 448:561-566.
83. Speicher MR, Carter NP (2005): The new cytogenetics: blurring the boundaries with molecular biology. Nat Rev Genet 6:782-792.
84. Taylor AM (2001): Chromosome instability syndromes. Best Pracl Res Clin Haematol 14:631-644.
85. Tomlins SA, Rhodes DR, Perner S, Dhanasekaran SM, Mehra R, Sun XW, Varambally S, Cao X, Tchinda J, Kuefer R, Lee C, Montie JE, Shah RB, Pienta KJ, Rubin MA, Chinnaiyan AM (2005): Recurrent fusion of TMPRSS2 and ETS transcription factor genes in prostate cancer. Science 310:644-648.
86. Wang JCY, Dick JE (2005): Cancer stem cells: lessons from leukemia. Trends Cell Biol 15:494-501.
87. Wheeler DL, Barrett T, Benson DA, Bryant SH, Canese K, Church DM, DiCuccio M, Edgar R, Federhen S, Helmberg W, Kenton DL, Khovayko O, Lipman DJ, Madden TL, Maglott DR, Ostell J, Pontius JU, Pruitt KD, Schuler GD, Schriml LM, Sequeira E, Sherry ST, Sirotkin K, Starchenko G, Suzek TO, Tatusov R, Tatusova TA, Wagner L, Yaschenko E (2005): Database resources of the National Center for Biotechnology Information. Nucleic Acids Res 33:D39-D45.
88. Wood LD, Parsons DW, Jones S, Lin J, Sjoblom T, Leary RJ, Shen D, Boca SM, Barber T, Ptak J, Silliman N, Szabo S, Dezso Z, Ustyanksky V, Nikolskaya T, Nikolsky Y, Karchin R, Wilson PA, Kaminker JS, Zhang Z, Croshaw R, Willis J, Dawson D, Shipitsin M, Willson JK, Sukumar S, Polyak K, Park BH, Pethiyagoda CL, Pant PV, Ballinger DG, Sparks AB, Hartigan J, Smith DR, Suh E, Papadopoulos N, Buckhaults P, Markowitz SD, Parmigiani G, Kinzler KW, Velculescu VE, Vogelstein B (2007): The genomic landscapes of human breast and colorectal cancers. Science 318:1108-1113.
89. Zhang Y, Rowley JD (2006): Chromatin structural elements and chromosomal translocations in leukemia. DNA Repair 5:1282-1297.